Quirk Michael C. (CIK 2063117) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-31). Recent activity: Sell SAGE (24,999 shares), Sell SAGE (7,962 shares), Sell SAGE (113 shares), Buy SAGE (933 shares), Sell SAGE (312 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Sell | 24,999 | $0 |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Sell | 7,962 | $0 |
| 2025-06-26 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Sell | 113 | $1,042 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Buy | 933 | $0 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Sell | 312 | $2,156 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Buy | 1,269 | $0 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Scientific Officer and Interim Head of R&D | Sell | 424 | $2,930 |
来源：SEC Form 4 申报文件 · 截至 2025-07-31